IDiyas

For the Inventor, By the Inventor

Frankfurt am Main, Germany

Bernd Henkel

USPTO Granted Patents = 17 

 

 

Average Co-Inventor Count = 3.7

ph-index = 4

Forward Citations = 55(Granted Patents)


Location History:

  • Hofheim, DE (2018)
  • Frankfurt-am-Main, DE (2015 - 2023)

Company Filing History:

goldMedal13 out of 1,451 
 
Sanofi
 patents
silverMedal4 out of 1,827 
 
Sanofi-a Ventis Deutschland Gmbh
 patents

Years Active: 2015-2023

Loading Chart...
Loading Chart...
Loading Chart...
17 patents (USPTO):
1. 11560402 - Method for cleavage of solid phase-bound peptides from the solid phase (2023-01-24),
2. 11028123 - Capping of unprotected amino groups during peptide synthesis (2021-06-08),
3. 11021512 - Method of preparing peptides comprising a lipophilically modified lysine side chain (2021-06-01),
4. 10758592 - Exendin-4 derivatives as dual GLP1/glucagon agonists (2020-09-01),
5. 10450343 - Synthesis of cyclic imide containing peptide products (2019-10-22),
6. 10253079 - Functionalized Exendin-4 derivatives (2019-04-09),
7. 10087221 - Synthesis of hydantoin containing peptide products (2018-10-02),
8. 9982029 - Exendin-4 derivatives as selective peptidic dual GLP-1/glucagon receptor agonists (2018-05-29),
9. 9932381 - Exendin-4 derivatives as selective glucagon receptor agonists (2018-04-03),
10. 9789165 - Exendin-4 peptide analogues as dual GLP-1/GIP receptor agonists (2017-10-17),
11. 9751926 - Dual GLP-1/GIP receptor agonists (2017-09-05),
12. 9750788 - Non-acylated exendin-4 peptide analogues (2017-09-05),
13. 9745360 - Dual GLP1/GIP or trigonal GLP1/GIP/glucagon agonists (2017-08-29),
14. 9694053 - Dual GLP-1/glucagon receptor agonists (2017-07-04),
15. 9670261 - Functionalized exendin-4 derivatives (2017-06-06),

Title: **Bernd Henkel: A Prominent Inventor in Peptide Synthesis**

Introduction

Bernd Henkel is a distinguished inventor located in Frankfurt am Main, Germany. With a remarkable portfolio of 17 patents, he has made significant contributions to the field of peptide synthesis and biochemistry. His innovative methods have advanced the efficiency and effectiveness of polypeptide production, showcasing his expertise and dedication to scientific advancement.

Latest Patents

Among his latest innovations, Bernd's notable patents include a method for the cleavage of solid phase-bound peptides from the solid phase. This invention introduces a technique that involves contacting the solid phase, to which the polypeptide is attached, with a composition primarily consisting of trifluoroacetic acid and 1,2-ethanedithiol, in a temperature range from about 23°C to about 29°C. Another commendable patent focuses on the capping of unprotected amino groups during peptide synthesis. This method details the synthesis of a polypeptide with a predetermined amino acid sequence, which consists of coupling cycles involving a capping step and a de-protecting step.

Career Highlights

Bernd Henkel has played a pivotal role in various esteemed companies, contributing his expertise to organizations like Sanofi and Sanofi-Aventis Deutschland GmbH. His work has not only enhanced the productivity of these corporations but has also positioned him as a leading figure in the biopharmaceutical sector.

Collaborations

In his remarkable career, Bernd has collaborated with talented individuals, including Torsten Haack and Andreas Evers. These collaborations have fostered innovative research and development in the realm of peptide synthesis, underscoring the importance of teamwork in achieving scientific breakthroughs.

Conclusion

In conclusion, Bernd Henkel stands out as a prolific inventor whose contributions to peptide synthesis are both impactful and far-reaching. With his skillful innovations and collaborative spirit, he continues to influence the fields of biology and chemistry, paving the way for future advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…